Peetz Christopher
CIK 0001614740 Name as filed on the most recent filing
Filed as Peetz Christopher (24)
38 transaction lines · from 24 filings · filed 2019-09-10 to 2026-08-11 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
38 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-10 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 2,300 disposed | 100.14 | 230,322.00 | Form 4, filing 0001614740-26-000012 | |
| 2026-08-10 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 6,017 disposed | 99.25 | 597,187.25 | Form 4, filing 0001614740-26-000012 | |
| 2026-08-10 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 11,683 disposed | 98.51 | 1,150,892.33 | Form 4, filing 0001614740-26-000012 | |
| 2026-07-06 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 12,134 disposed | 121.65 | 1,476,101.10 | Form 4, filing 0001614740-26-000011 | |
| 2026-07-06 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 4,181 disposed | 122.34 | 511,503.54 | Form 4, filing 0001614740-26-000011 | |
| 2026-07-06 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 1,975 disposed | 123.74 | 244,386.50 | Form 4, filing 0001614740-26-000011 | |
| 2026-07-06 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 1,710 disposed | 124.79 | 213,390.90 | Form 4, filing 0001614740-26-000011 | |
| 2026-06-01 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 16,595 disposed | 95.34 | 1,582,167.30 | Form 4, filing 0001614740-26-000010 | |
| 2026-06-01 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 6,926 disposed | 96.15 | 665,934.90 | Form 4, filing 0001614740-26-000010 | |
| 2026-06-01 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 2,602 disposed | 94.64 | 246,253.28 | Form 4, filing 0001614740-26-000010 | |
| 2026-06-01 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 1,973 disposed | 97.56 | 192,485.88 | Form 4, filing 0001614740-26-000010 | |
| 2026-06-01 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 1,021 disposed | 98.20 | 100,262.20 | Form 4, filing 0001614740-26-000010 | |
| 2026-06-01 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 883 disposed | 99.66 | 87,999.78 | Form 4, filing 0001614740-26-000010 | |
| 2026-03-16 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 40,985 disposed | 91.98 | 3,769,714.23 | Form 4, filing 0001614740-26-000009 | |
| 2026-02-02 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 9,108 disposed | 103.30 | 940,888.28 | Form 4, filing 0001614740-26-000007 | |
| 2026-01-26 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 6,831 disposed | 96.19 | 657,087.55 | Form 4, filing 0001614740-26-000003 | |
| 2026-01-22 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 7,098 disposed | 93.33 | 662,422.27 | Form 4, filing 0001614740-26-000002 | |
| 2025-08-11 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 40,000 disposed | 62.00 | 2,480,000.00 | Form 4, filing 0001415889-25-021521 | |
| 2025-08-07 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 40,000 disposed | 55.25 | 2,210,040.00 | Form 4, filing 0001415889-25-021350 | |
| 2025-03-17 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 27,279 disposed | 44.21 | 1,206,121.89 | Form 4, filing 0001415889-25-008556 | |
| 2025-03-03 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 20,608 disposed | 47.19 | 972,491.52 | Form 4, filing 0001415889-25-006524 | |
| 2025-03-03 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 19,392 disposed | 46.61 | 903,861.12 | Form 4, filing 0001415889-25-006524 | |
| 2025-02-03 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 9,102 disposed | 48.22 | 438,921.20 | Form 4, filing 0001415889-25-002981 | |
| 2025-01-24 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 6,837 disposed | 47.92 | 327,658.44 | Form 4, filing 0001415889-25-002134 | |
| 2025-01-07 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 7,489 disposed | 42.82 | 320,643.78 | Form 4, filing 0001415889-25-001143 | |
| 2024-02-02 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 6,013 disposed | 26.19 | 157,491.29 | Form 4, filing 0001415889-24-002754 | |
| 2024-01-08 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 5,209 disposed | 28.03 | 146,033.27 | Form 4, filing 0001415889-24-000881 | |
| 2023-07-03 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 5,498 disposed | 25.65 | 141,005.01 | Form 4, filing 0001209191-23-041330 | |
| 2023-01-09 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 5,159 disposed | 20.62 | 106,390.45 | Form 4, filing 0001415889-24-008313 | |
| 2021-11-24 |
Mirum Pharmaceuticals, Inc. MIRM |
P, Open-market purchase | 7,000 acquired | 14.40 | 100,800.00 | Form 4, filing 0001209191-21-067067 | |
| 2021-10-01 |
Mirum Pharmaceuticals, Inc. MIRM |
S, Open-market sale | 3,672 disposed | 19.26 | 70,708.03 | Form 4, filing 0001209191-21-058610 | |
| 2021-09-23 |
Alpine Immune Sciences, Inc. ALPN |
P, Open-market purchase | 1,900 acquired | 10.17 | 19,323.00 | Form 4, filing 0001626199-21-000131 | |
| 2021-09-23 |
Alpine Immune Sciences, Inc. ALPN |
S, Open-market sale | 1,900 acquired | 10.17 | 19,323.00 | Form 4, filing 0001626199-21-000126 | |
| 2020-12-23 |
Mirum Pharmaceuticals, Inc. MIRM |
P, Open-market purchase | 3,000 acquired | 18.76 | 56,280.00 | Form 4, filing 0001209191-20-065165 | |
| 2020-12-23 |
Mirum Pharmaceuticals, Inc. MIRM |
P, Open-market purchase | 2,000 acquired | 18.60 | 37,200.00 | Form 4, filing 0001209191-20-065165 | |
| 2019-09-09 |
Mirum Pharmaceuticals, Inc. MIRM |
P, Open-market purchase | 2,320 acquired | 11.35 | 26,332.00 | Form 4, filing 0001209191-19-049090 | |
| 2019-09-09 |
Mirum Pharmaceuticals, Inc. MIRM |
P, Open-market purchase | 2,000 acquired | 10.90 | 21,800.00 | Form 4, filing 0001209191-19-049090 | |
| 2019-09-06 |
Mirum Pharmaceuticals, Inc. MIRM |
P, Open-market purchase | 4,750 acquired | 10.91 | 51,805.88 | Form 4, filing 0001209191-19-049090 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 7
- Open-market sale 31
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Peetz Christopher, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001614740
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6